| Sarcopenia in chronic liver disease: Mechanisms and countermeasures SL Allen, JI Quinlan, A Dhaliwal, MJ Armstrong, AM Elsharkawy, CA Greig, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 320 (3 …, 2021 | 55 | 2021 |
| Protein source and quality for skeletal muscle anabolism in young and older adults: a systematic review and meta-analysis PT Morgan, DO Harris, RN Marshall, JI Quinlan, SJ Edwards, SL Allen, ... The Journal of nutrition 151 (7), 1901-1920, 2021 | 29 | 2021 |
| The effect of young and old ex vivo human serum on cellular protein synthesis and growth in an in vitro model of aging SL Allen, RN Marshall, SJ Edwards, JM Lord, GG Lavery, L Breen American Journal of Physiology-Cell Physiology 321 (1), C26-C37, 2021 | 18 | 2021 |
| Improving physiological relevance of cell culture: the possibilities, considerations, and future directions of the ex vivo coculture model SL Allen, BT Elliott, BP Carson, L Breen American Journal of Physiology-Cell Physiology 324 (2), C420-C427, 2023 | 8 | 2023 |
| (-)-Epicatechin and its colonic metabolite hippuric acid protect against dexamethasone-induced atrophy in skeletal muscle cells SJ Edwards, S Carter, T Nicholson, SL Allen, PT Morgan, SW Jones, ... The Journal of Nutritional Biochemistry 110, 109150, 2022 | 8 | 2022 |
| The effect of ex vivo human serum from liver disease patients on cellular protein synthesis and growth SL Allen, AP Seabright, JI Quinlan, A Dhaliwal, FR Williams, NHF Fine, ... Cells 11 (7), 1098, 2022 | 8 | 2022 |
| Evaluation of the mechanisms of sarcopenia in chronic inflammatory disease: protocol for a prospective cohort study A Dhaliwal, FR Williams, JI Quinlan, SL Allen, C Greig, A Filer, K Raza, ... Skeletal muscle 11 (1), 27, 2021 | 7 | 2021 |
| Impaired lower limb muscle mass, quality and function in end stage liver disease: A cross‐sectional study JI Quinlan, A Dhaliwal, FR Williams, SL Allen, S Choudhary, A Rowlands, ... Experimental Physiology 108 (8), 1066-1079, 2023 | 1 | 2023 |
| Feasibility, Efficacy, and Safety of Percutaneous Muscle Biopsies in Patients With Chronic Liver Disease JI Quinlan, A Dhaliwal, F Williams, SL Allen, L Breen, CA Greig, JM Lord, ... Frontiers in physiology 12, 817152, 2022 | 1 | 2022 |
| POS0591-HPR THE UTILITY OF NOVEL ACCELEROMETER METRICS FOR CHARACTERISING CLINICAL FEATURES IN PATIENTS LIVING WITH RHEUMATOID ARTHRITIS S Fenton, S Allen, C O’brien, A Rowlands, J Duda, JV van Zanten, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 566-567, 2023 | | 2023 |
| Making Cell Culture More Physiological: Improving physiological relevance of cell culture: the possibilities, considerations, and future directions of the ex vivo coculture model SL Allen, BT Elliott, BP Carson, L Breen American Journal of Physiology-Cell Physiology 324 (2), C420, 2023 | | 2023 |
| Impaired lower limb muscle mass, quality and function in end stage liver disease JI Quinlan, A Dhaliwal, FR Williams, SL Allen, S Choudhary, A Rowlands, ... | | 2023 |
| RELATIONSHIP OF TRUNCAL, UPPER AND LOWER LIMB MUSCLE MASS AND STRENGTH IN PATIENTS WITH END-STAGE LIVER DISEASE: A UK PROSPECTIVE STUDY A Dhaliwal, JI Quinlan, FR Williams, SL Allen, S Choudhary, L Breen, ... HEPATOLOGY 76, S1170-S1170, 2022 | | 2022 |
| THE AETIOLOGY OF END-STAGE LIVER DISEASE IMPACTS ON THE SITE AND SEVERITY OF MUSCLE WEAKNESS IN PATIENTS AWAITING LIVER TRANSPLANTATION: A PROSPECTIVE CASE-CONTROL STUDY A Dhaliwal, JI Quinlan, FR Williams, SL Allen, S Choudhary, L Breen, ... HEPATOLOGY 76, S1171-S1171, 2022 | | 2022 |
| P24 The relationship of truncal, upper and lower limb muscle mass, strength and performance in patients with End-Stage Liver Disease: A UK prospective study A Dhaliwal, J Quinlan, F Williams, S Allen, S Choudhary, L Breen, ... Gut 71 (Suppl 3), A49-A49, 2022 | | 2022 |
| P67 Patients with end-stage liver disease are physically inactive and unable to sustain moderate intensity physical activity: A prospective home-based case-control UK Study FR Williams, JI Quinlan, A Dhaliwal, A Rowlands, SL Allen, L Breen, ... Gut 71 (Suppl 3), A81-A82, 2022 | | 2022 |
| O13 End-stage liver disease aetiology impacts on the site and severity of muscle weakness in patients awaiting Liver Transplantation: A prospective case-control study A Dhaliwal, J Quinlan, F Williams, S Allen, T Nicholson, S Choudhary, ... Gut 71 (Suppl 3), A9-A11, 2022 | | 2022 |
| Sarcopenia in chronic liver disease: novel mechanistic insights SL Allen University of Birmingham, 2022 | | 2022 |
| The regulatory protein and gene expression profile of skeletal muscle in chronic liver disease patients S Allen, J Quinlan, A Dhaliwal, T Nicholson, F Williams, M Armstrong, ... Journal of Hepatology 77, S364-S365, 2022 | | 2022 |
| In vitro skeletal muscle cell atrophy and mitochondrial dysfunction after exposure to human serum from patients with ESLD and NAFLD S Allen, A Seabright, J Quinlan, A Dhaliwal, F Williams, N Fine, D Hodson, ... JOURNAL OF HEPATOLOGY 75, S342-S343, 2021 | | 2021 |
